Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial

BACKGROUND: Colorectal cancer (CRC) is the second most common cause of all cancer deaths in Europe and the Western world with a lifetime risk of approximately 5%. Despite several improvements in the treatment of patients with unresectable CRC prognosis is poor and there is the need of developing new...

Descripción completa

Detalles Bibliográficos
Autores principales: Burock, Susen, Daum, Severin, Keilholz, Ulrich, Neumann, Konrad, Walther, Wolfgang, Stein, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856000/
https://www.ncbi.nlm.nih.gov/pubmed/29544454
http://dx.doi.org/10.1186/s12885-018-4197-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856000/
https://www.ncbi.nlm.nih.gov/pubmed/29544454
http://dx.doi.org/10.1186/s12885-018-4197-9

Ejemplares similares